These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 31810233)

  • 21. Intestinal microflora as a therapeutic target in inflammatory bowel disease.
    Mitsuyama K; Toyonaga A; Sata M
    J Gastroenterol; 2002 Nov; 37 Suppl 14():73-7. PubMed ID: 12572870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of probiotic therapy in IBD.
    Isaacs K; Herfarth H
    Inflamm Bowel Dis; 2008 Nov; 14(11):1597-605. PubMed ID: 18421762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative efficacy and tolerability of probiotic, prebiotic, and synbiotic formulations for adult patients with mild-moderate ulcerative colitis in an adjunctive therapy: A network meta-analysis.
    Zhou S; Wang M; Li W; Zhang Y; Zhao T; Song Q; Cong J
    Clin Nutr; 2024 Jan; 43(1):20-30. PubMed ID: 37995508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease.
    Ghouri YA; Richards DM; Rahimi EF; Krill JT; Jelinek KA; DuPont AW
    Clin Exp Gastroenterol; 2014; 7():473-87. PubMed ID: 25525379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of probiotic and synbiotic supplementation on biomarkers of inflammation and oxidative stress in diabetic patients: A systematic review and meta-analysis of randomized controlled trials.
    Zheng HJ; Guo J; Jia Q; Huang YS; Huang WJ; Zhang W; Zhang F; Liu WJ; Wang Y
    Pharmacol Res; 2019 Apr; 142():303-313. PubMed ID: 30794924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probiotics, prebiotics, and synbiotics for the improvement of metabolic profiles in patients with chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials.
    Zheng HJ; Guo J; Wang Q; Wang L; Wang Y; Zhang F; Huang WJ; Zhang W; Liu WJ; Wang Y
    Crit Rev Food Sci Nutr; 2021; 61(4):577-598. PubMed ID: 32329633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prebiotic, Probiotic, and Synbiotic Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-analysis.
    McFarlane C; Ramos CI; Johnson DW; Campbell KL
    J Ren Nutr; 2019 May; 29(3):209-220. PubMed ID: 30366767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Harms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota: A Systematic Review.
    Bafeta A; Koh M; Riveros C; Ravaud P
    Ann Intern Med; 2018 Aug; 169(4):240-247. PubMed ID: 30014150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of probiotics, prebiotics, and synbiotics for the prevention of colorectal cancer and precancerous lesion in high-risk populations: A systematic review and meta-analysis of randomized controlled trials.
    Kan HX; Cao Y; Ma Y; Zhang YL; Wang J; Li J; Li JN
    J Dig Dis; 2024 Jan; 25(1):14-26. PubMed ID: 38126945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children.
    Guandalini S; Cernat E; Moscoso D
    Benef Microbes; 2015; 6(2):209-17. PubMed ID: 25391345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)-A Critical Review.
    Jakubczyk D; Leszczyńska K; Górska S
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32630805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reviewing the potential of probiotics, prebiotics and synbiotics: advancements in treatment of ulcerative colitis.
    Jadhav A; Jagtap S; Vyavahare S; Sharbidre A; Kunchiraman B
    Front Cell Infect Microbiol; 2023; 13():1268041. PubMed ID: 38145046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probiotics in inflammatory bowel disease: a critical review.
    Tamboli CP; Caucheteux C; Cortot A; Colombel JF; Desreumaux P
    Best Pract Res Clin Gastroenterol; 2003 Oct; 17(5):805-20. PubMed ID: 14507590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probiotics for inflammatory bowel diseases: a promising adjuvant treatment.
    Coqueiro AY; Raizel R; Bonvini A; Tirapegui J; Rogero MM
    Int J Food Sci Nutr; 2019 Feb; 70(1):20-29. PubMed ID: 29804478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probiotic bacteria in the prevention and the treatment of inflammatory bowel disease.
    Fedorak R; Demeria D
    Gastroenterol Clin North Am; 2012 Dec; 41(4):821-42. PubMed ID: 23101689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and Safety of Probiotics, Prebiotics and Synbiotics in the Treatment of Irritable Bowel Syndrome: A systematic review and meta-analysis.
    Asha MZ; Khalil SFH
    Sultan Qaboos Univ Med J; 2020 Feb; 20(1):e13-e24. PubMed ID: 32190365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prebiotics, synbiotics and inflammatory bowel disease.
    Steed H; Macfarlane GT; Macfarlane S
    Mol Nutr Food Res; 2008 Aug; 52(8):898-905. PubMed ID: 18383235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is probiotic use beneficial for skin lesions in patients with inflammatory bowel disease?
    Satta R; Pes GM; Rocchi C; Pes MC; Dore MP
    J Dermatolog Treat; 2019 Sep; 30(6):612-616. PubMed ID: 30244616
    [No Abstract]   [Full Text] [Related]  

  • 39. Probiotics and prebiotics in Crohn's disease therapies.
    Lichtenstein L; Avni-Biron I; Ben-Bassat O
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):81-8. PubMed ID: 27048899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn's disease.
    Bjarnason I; Sission G; Hayee B
    Inflammopharmacology; 2019 Jun; 27(3):465-473. PubMed ID: 31054010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.